Phibro Animal Health | PAHC - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Phibro Animal Health

Phibro Animal Health reported $170.13M in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
Align Technology ALGN:US USD 282.49M 1.32M
ANI Pharmaceuticals ANIP:US USD 37.71M 1.38M
Bristol-Myers Squibb BMY:US USD 2.56B 45M
Corcept Therapeutics CORT:US USD 1.39M 94K
Depomed DEPO:US USD 5.47M 447K
Eli Lilly LLY:US USD 1.63B 78.6M
Endo International ENDP:US USD 167.44M 51.37M
Henry Schein HSIC:US USD 2.09B 278M
Idexx Laboratories IDXX:US USD 357.22M 13.58M
Knight Therapeutics Inc GUD:CN CAD 41.84M 2.93M
Merck & Co MRK:US USD 3.35B 491M
Nektar Therapeutics NKTR:US USD 7.06M 827K
Pacira PCRX:US USD 49.02M 12.9M
Patterson Companies PDCO:US USD 1.26B 40.23M
Phibro Animal Health PAHC:US USD 170.13M 2.87M
Prestige Brands PBH:US USD 132.1M 6.98M
Supernus Pharmaceuticals SUPN:US USD 23.46M 506K
Zoetis ZTS:US USD 554M 97M